Go Pro

Core Laboratories (CLB) Competitors

Core Laboratories logo
$12.64 +0.19 (+1.53%)
Closing price 08/17/2026 03:58 PM Eastern
Extended Trading
$12.58 -0.06 (-0.48%)
As of 08:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CLB vs. PTEN, HAL, HP, MGY, and NBR

Should you buy Core Laboratories stock or one of its competitors? Core Laboratories's main competitors and comparable companies include Patterson-UTI Energy (PTEN), Halliburton (HAL), Helmerich & Payne (HP), Magnolia Oil & Gas (MGY), and Nabors Industries (NBR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "energy" sector.

How does Core Laboratories compare to Patterson-UTI Energy?

Core Laboratories (NYSE:CLB) and Patterson-UTI Energy (NASDAQ:PTEN) are both energy companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.

Core Laboratories has a beta of 1.03, suggesting that its stock price is 3% more volatile than the broader market. Comparatively, Patterson-UTI Energy has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market.

Core Laboratories has a net margin of 5.10% compared to Patterson-UTI Energy's net margin of -1.92%. Core Laboratories' return on equity of 10.03% beat Patterson-UTI Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Core Laboratories5.10% 10.03% 4.71%
Patterson-UTI Energy -1.92%-1.68%-0.98%

97.8% of Core Laboratories shares are held by institutional investors. Comparatively, 97.9% of Patterson-UTI Energy shares are held by institutional investors. 1.3% of Core Laboratories shares are held by insiders. Comparatively, 2.2% of Patterson-UTI Energy shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Core Laboratories presently has a consensus target price of $21.00, indicating a potential upside of 66.14%. Patterson-UTI Energy has a consensus target price of $12.95, indicating a potential upside of 5.97%. Given Core Laboratories' higher probable upside, research analysts plainly believe Core Laboratories is more favorable than Patterson-UTI Energy.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Core Laboratories
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Patterson-UTI Energy
1 Sell rating(s)
4 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.67

In the previous week, Patterson-UTI Energy had 18 more articles in the media than Core Laboratories. MarketBeat recorded 22 mentions for Patterson-UTI Energy and 4 mentions for Core Laboratories. Patterson-UTI Energy's average media sentiment score of 0.88 beat Core Laboratories' score of 0.85 indicating that Patterson-UTI Energy is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Core Laboratories
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Patterson-UTI Energy
6 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Core Laboratories has higher earnings, but lower revenue than Patterson-UTI Energy. Patterson-UTI Energy is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Core Laboratories$526.52M1.10$29.67M$0.5622.57
Patterson-UTI Energy$4.83B0.97-$93.64M-$0.23N/A

Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.3%. Patterson-UTI Energy pays an annual dividend of $0.40 per share and has a dividend yield of 3.3%. Core Laboratories pays out 7.1% of its earnings in the form of a dividend. Patterson-UTI Energy pays out -173.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Patterson-UTI Energy is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Patterson-UTI Energy beats Core Laboratories on 10 of the 19 factors compared between the two stocks.

How does Core Laboratories compare to Halliburton?

Halliburton (NYSE:HAL) and Core Laboratories (NYSE:CLB) are both energy companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment.

Halliburton has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market. Comparatively, Core Laboratories has a beta of 1.03, indicating that its share price is 3% more volatile than the broader market.

Halliburton has a net margin of 7.16% compared to Core Laboratories' net margin of 5.10%. Halliburton's return on equity of 18.71% beat Core Laboratories' return on equity.

Company Net Margins Return on Equity Return on Assets
Halliburton7.16% 18.71% 7.89%
Core Laboratories 5.10%10.03%4.71%

Halliburton pays an annual dividend of $0.68 per share and has a dividend yield of 2.0%. Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.3%. Halliburton pays out 35.6% of its earnings in the form of a dividend. Core Laboratories pays out 7.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Halliburton has increased its dividend for 4 consecutive years. Halliburton is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

85.2% of Halliburton shares are owned by institutional investors. Comparatively, 97.8% of Core Laboratories shares are owned by institutional investors. 0.6% of Halliburton shares are owned by company insiders. Comparatively, 1.3% of Core Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Halliburton had 17 more articles in the media than Core Laboratories. MarketBeat recorded 21 mentions for Halliburton and 4 mentions for Core Laboratories. Halliburton's average media sentiment score of 0.99 beat Core Laboratories' score of 0.85 indicating that Halliburton is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Halliburton
17 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
2 Very Negative mention(s)
Positive
Core Laboratories
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Halliburton currently has a consensus target price of $43.10, suggesting a potential upside of 23.80%. Core Laboratories has a consensus target price of $21.00, suggesting a potential upside of 66.14%. Given Core Laboratories' higher probable upside, analysts clearly believe Core Laboratories is more favorable than Halliburton.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Halliburton
1 Sell rating(s)
6 Hold rating(s)
18 Buy rating(s)
0 Strong Buy rating(s)
2.68
Core Laboratories
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Halliburton has higher revenue and earnings than Core Laboratories. Halliburton is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Halliburton$22.37B1.30$1.28B$1.9118.23
Core Laboratories$526.52M1.10$29.67M$0.5622.57

Summary

Halliburton beats Core Laboratories on 13 of the 19 factors compared between the two stocks.

How does Core Laboratories compare to Helmerich & Payne?

Helmerich & Payne (NYSE:HP) and Core Laboratories (NYSE:CLB) are both energy companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability and risk.

96.1% of Helmerich & Payne shares are owned by institutional investors. Comparatively, 97.8% of Core Laboratories shares are owned by institutional investors. 4.4% of Helmerich & Payne shares are owned by company insiders. Comparatively, 1.3% of Core Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Helmerich & Payne had 4 more articles in the media than Core Laboratories. MarketBeat recorded 8 mentions for Helmerich & Payne and 4 mentions for Core Laboratories. Core Laboratories' average media sentiment score of 0.85 beat Helmerich & Payne's score of 0.39 indicating that Core Laboratories is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Helmerich & Payne
1 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Core Laboratories
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Helmerich & Payne has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, Core Laboratories has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market.

Helmerich & Payne pays an annual dividend of $1.00 per share and has a dividend yield of 2.2%. Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.3%. Helmerich & Payne pays out -70.9% of its earnings in the form of a dividend. Core Laboratories pays out 7.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Helmerich & Payne is clearly the better dividend stock, given its higher yield and lower payout ratio.

Helmerich & Payne currently has a consensus target price of $40.50, indicating a potential downside of 9.46%. Core Laboratories has a consensus target price of $21.00, indicating a potential upside of 66.14%. Given Core Laboratories' stronger consensus rating and higher possible upside, analysts plainly believe Core Laboratories is more favorable than Helmerich & Payne.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Helmerich & Payne
1 Sell rating(s)
5 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.36
Core Laboratories
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Core Laboratories has lower revenue, but higher earnings than Helmerich & Payne. Helmerich & Payne is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Helmerich & Payne$3.75B1.19-$163.70M-$1.41N/A
Core Laboratories$526.52M1.10$29.67M$0.5622.57

Core Laboratories has a net margin of 5.10% compared to Helmerich & Payne's net margin of -3.43%. Core Laboratories' return on equity of 10.03% beat Helmerich & Payne's return on equity.

Company Net Margins Return on Equity Return on Assets
Helmerich & Payne-3.43% -2.35% -0.99%
Core Laboratories 5.10%10.03%4.71%

Summary

Core Laboratories beats Helmerich & Payne on 11 of the 18 factors compared between the two stocks.

How does Core Laboratories compare to Magnolia Oil & Gas?

Magnolia Oil & Gas (NYSE:MGY) and Core Laboratories (NYSE:CLB) are both energy companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations.

94.7% of Magnolia Oil & Gas shares are held by institutional investors. Comparatively, 97.8% of Core Laboratories shares are held by institutional investors. 0.9% of Magnolia Oil & Gas shares are held by company insiders. Comparatively, 1.3% of Core Laboratories shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Magnolia Oil & Gas currently has a consensus target price of $31.62, suggesting a potential upside of 18.10%. Core Laboratories has a consensus target price of $21.00, suggesting a potential upside of 66.14%. Given Core Laboratories' higher probable upside, analysts plainly believe Core Laboratories is more favorable than Magnolia Oil & Gas.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Magnolia Oil & Gas
0 Sell rating(s)
7 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.67
Core Laboratories
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Magnolia Oil & Gas has higher revenue and earnings than Core Laboratories. Magnolia Oil & Gas is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Magnolia Oil & Gas$1.48B4.29$325.25M$2.2811.74
Core Laboratories$526.52M1.10$29.67M$0.5622.57

Magnolia Oil & Gas has a beta of 0.72, meaning that its stock price is 28% less volatile than the broader market. Comparatively, Core Laboratories has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market.

Magnolia Oil & Gas has a net margin of 28.77% compared to Core Laboratories' net margin of 5.10%. Magnolia Oil & Gas' return on equity of 21.04% beat Core Laboratories' return on equity.

Company Net Margins Return on Equity Return on Assets
Magnolia Oil & Gas28.77% 21.04% 14.46%
Core Laboratories 5.10%10.03%4.71%

Magnolia Oil & Gas pays an annual dividend of $0.72 per share and has a dividend yield of 2.7%. Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.3%. Magnolia Oil & Gas pays out 31.6% of its earnings in the form of a dividend. Core Laboratories pays out 7.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Magnolia Oil & Gas has raised its dividend for 3 consecutive years. Magnolia Oil & Gas is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Magnolia Oil & Gas had 15 more articles in the media than Core Laboratories. MarketBeat recorded 19 mentions for Magnolia Oil & Gas and 4 mentions for Core Laboratories. Core Laboratories' average media sentiment score of 0.85 beat Magnolia Oil & Gas' score of 0.75 indicating that Core Laboratories is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Magnolia Oil & Gas
7 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive
Core Laboratories
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Magnolia Oil & Gas beats Core Laboratories on 13 of the 20 factors compared between the two stocks.

How does Core Laboratories compare to Nabors Industries?

Core Laboratories (NYSE:CLB) and Nabors Industries (NYSE:NBR) are both small-cap energy companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk and analyst recommendations.

Nabors Industries has higher revenue and earnings than Core Laboratories. Nabors Industries is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Core Laboratories$526.52M1.10$29.67M$0.5622.57
Nabors Industries$3.21B0.45$286.62M$13.447.21

Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.3%. Nabors Industries pays an annual dividend of $0.04 per share and has a dividend yield of 0.0%. Core Laboratories pays out 7.1% of its earnings in the form of a dividend. Nabors Industries pays out 0.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Nabors Industries has a net margin of 7.64% compared to Core Laboratories' net margin of 5.10%. Core Laboratories' return on equity of 10.03% beat Nabors Industries' return on equity.

Company Net Margins Return on Equity Return on Assets
Core Laboratories5.10% 10.03% 4.71%
Nabors Industries 7.64%-7.06%-1.45%

Core Laboratories has a beta of 1.03, suggesting that its stock price is 3% more volatile than the broader market. Comparatively, Nabors Industries has a beta of 0.98, suggesting that its stock price is 2% less volatile than the broader market.

In the previous week, Nabors Industries had 1 more articles in the media than Core Laboratories. MarketBeat recorded 5 mentions for Nabors Industries and 4 mentions for Core Laboratories. Core Laboratories' average media sentiment score of 0.85 beat Nabors Industries' score of 0.03 indicating that Core Laboratories is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Core Laboratories
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nabors Industries
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Core Laboratories currently has a consensus price target of $21.00, suggesting a potential upside of 66.14%. Nabors Industries has a consensus price target of $101.14, suggesting a potential upside of 4.40%. Given Core Laboratories' stronger consensus rating and higher probable upside, analysts clearly believe Core Laboratories is more favorable than Nabors Industries.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Core Laboratories
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Nabors Industries
0 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

97.8% of Core Laboratories shares are held by institutional investors. Comparatively, 81.9% of Nabors Industries shares are held by institutional investors. 1.3% of Core Laboratories shares are held by company insiders. Comparatively, 5.3% of Nabors Industries shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Core Laboratories beats Nabors Industries on 10 of the 18 factors compared between the two stocks.

Get Core Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLB vs. The Competition

MetricCore LaboratoriesEnergy Equipment & Services IndustryEnergy SectorNYSE Exchange
Market Cap$571.26M$3.78B$9.80B$24.32B
Dividend Yield0.32%13.36%11.64%3.69%
P/E Ratio22.5744.5320.3430.50
Price / Sales1.1032.32394.2320.14
Price / Cash11.6521.3936.0120.48
Price / Book2.162.253.954.92
Net Income$29.67M$67.53M$4.32B$1.07B
7 Day Performance1.51%2.58%2.10%0.13%
1 Month Performance11.71%6.61%5.50%2.60%
1 Year Performance20.21%57.75%40.47%18.42%

Core Laboratories Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLB
Core Laboratories
4.4307 of 5 stars
$12.64
+1.5%
$21.00
+66.1%
+21.1%$571.26M$526.52M22.573,300
PTEN
Patterson-UTI Energy
2.8856 of 5 stars
$11.04
+0.5%
$12.95
+17.3%
+127.1%$4.21B$4.67BN/A7,900
HAL
Halliburton
4.8711 of 5 stars
$33.73
+0.3%
$43.10
+27.8%
+64.7%$28.06B$22.18B17.6346,000
HP
Helmerich & Payne
1.914 of 5 stars
$42.63
+1.8%
$40.50
-5.0%
+153.1%$4.24B$3.75BN/A6,200
MGY
Magnolia Oil & Gas
4.8139 of 5 stars
$26.04
+0.1%
$31.58
+21.3%
+13.5%$4.82B$1.31B11.43210

Related Companies and Tools


This page (NYSE:CLB) was last updated on 8/18/2026 by MarketBeat.com Staff.
From Our Partners